Vijay Mahant

Directeur Général chez Renova Therapeutics, Inc.

Health Technology

Consumer Services

Postes actifs de Vijay Mahant

Sociétés	Poste	Début	Fin
Batu Biologics, Inc. Batu Biologics, Inc. Pharmaceuticals: MajorHealth Technology Batu Biologics, Inc. operates as an immunotherapy company. It develops therapeutics that addresses the multi-factorial and multi-dimensional nature of cancer. The company was founded by Samuel C. Wagner, Thomas Ichim and Dimitri Theofilopoulos and is headquartered in San Diego, CA.	Corporate Officer/Principal	-	-
Renova Therapeutics, Inc. Renova Therapeutics, Inc. BiotechnologyHealth Technology Renova Therapeutics, Inc. operates as a biopharmaceutical company. The firm is developing definitive, one-time gene therapies and peptide infusion treatments to restore the health of people suffering from chronic diseases. Its product, RT-100, is a treatment that delivers a therapeutic gene directly to the heart during a routine outpatient procedure and has the potential to increase heart function in patients with CHF. The company was founded by Jack W. Reich, H. Kirk Hammond and Craig Andrews in 2009 and is headquartered in San Diego, CA.	Directeur/Membre du Conseil	-	-
	Directeur Général	16/09/2021	-

Sociétés	Poste	Début	Fin
ONCOLOGY PHARMA INC.	Directeur des opérations	15/10/2019	-
ONCOLOGY PHARMA INC.	Directeur Technique/Scientifique/R&D	15/10/2019	-

Loughborough University

Doctorate Degree

Internationale

Etats-Unis	4
Royaume-Uni	2

Opérationnelle

Chief Operating Officer	1
Chief Tech/Sci/R&D Officer	1
Corporate Officer/Principal	1

Sectorielle

Health Technology	4
Consumer Services	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	1
ONCOLOGY PHARMA INC.	Health Technology

Entreprise privées	2
Batu Biologics, Inc. Batu Biologics, Inc. Pharmaceuticals: MajorHealth Technology Batu Biologics, Inc. operates as an immunotherapy company. It develops therapeutics that addresses the multi-factorial and multi-dimensional nature of cancer. The company was founded by Samuel C. Wagner, Thomas Ichim and Dimitri Theofilopoulos and is headquartered in San Diego, CA.	Health Technology
Renova Therapeutics, Inc. Renova Therapeutics, Inc. BiotechnologyHealth Technology Renova Therapeutics, Inc. operates as a biopharmaceutical company. The firm is developing definitive, one-time gene therapies and peptide infusion treatments to restore the health of people suffering from chronic diseases. Its product, RT-100, is a treatment that delivers a therapeutic gene directly to the heart during a routine outpatient procedure and has the potential to increase heart function in patients with CHF. The company was founded by Jack W. Reich, H. Kirk Hammond and Craig Andrews in 2009 and is headquartered in San Diego, CA.	Health Technology

Entreprise privées

Health Technology